Stem cell-based tissue-engineered laryngeal replacement

Tahera Ansari, Peggy Lange, Aaron Southgate, Karin Greco, Carla Carvalho, Leanne Partington, Anthony Bullock, Sheila Macneil, Mark W. Lowdell, Paul D. Sibbons, Martin A. Birchall

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Patients with laryngeal disorders may have severe morbidity relating to swallowing, vocalization, and respiratory function, for which conventional therapies are suboptimal. A tissue-engineered approach would aim to restore the vocal folds and maintain respiratory function while limiting the extent of scarring in the regenerated tissue. Under Good Laboratory Practice conditions, we decellularized porcine larynges, using detergents and enzymes under negative pressure to produce an acellular scaffold comprising cartilage, muscle, and mucosa. To assess safety and functionality before clinical trials, a decellularized hemilarynx seeded with human bone marrow-derived mesenchymal stem cells and a tissue-engineered oral mucosal sheet was implanted orthotopically into six pigs. The seeded grafts were left in situ for 6 months and assessed using computed tomography imaging, bronchoscopy, and mucosal brushings, together with vocal recording and histological analysis on explantation. The graft caused no adverse respiratory function, nor did it impact swallowing or vocalization. Rudimentary vocal folds covered by contiguous epithelium were easily identifiable. In conclusion, the proposed tissue-engineered approach represents a viable alternative treatment for laryngeal defects.

Original languageEnglish (US)
Pages (from-to)677-687
Number of pages11
JournalStem cells translational medicine
Volume6
Issue number2
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

Fingerprint

Stem Cells
Vocal Cords
Deglutition
Swine
Transplants
Bronchoscopy
Larynx
Mesenchymal Stromal Cells
Detergents
Cartilage
Cicatrix
Mucous Membrane
Epithelium
Bone Marrow
Tomography
Clinical Trials
Morbidity
Safety
Pressure
Muscles

Keywords

  • Animal model
  • Human stem cell
  • Larynx
  • Tissue engineering
  • Tissue scaffold

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Ansari, T., Lange, P., Southgate, A., Greco, K., Carvalho, C., Partington, L., ... Birchall, M. A. (2017). Stem cell-based tissue-engineered laryngeal replacement. Stem cells translational medicine, 6(2), 677-687. https://doi.org/10.5966/sctm.2016-0130

Stem cell-based tissue-engineered laryngeal replacement. / Ansari, Tahera; Lange, Peggy; Southgate, Aaron; Greco, Karin; Carvalho, Carla; Partington, Leanne; Bullock, Anthony; Macneil, Sheila; Lowdell, Mark W.; Sibbons, Paul D.; Birchall, Martin A.

In: Stem cells translational medicine, Vol. 6, No. 2, 01.02.2017, p. 677-687.

Research output: Contribution to journalArticle

Ansari, T, Lange, P, Southgate, A, Greco, K, Carvalho, C, Partington, L, Bullock, A, Macneil, S, Lowdell, MW, Sibbons, PD & Birchall, MA 2017, 'Stem cell-based tissue-engineered laryngeal replacement', Stem cells translational medicine, vol. 6, no. 2, pp. 677-687. https://doi.org/10.5966/sctm.2016-0130
Ansari T, Lange P, Southgate A, Greco K, Carvalho C, Partington L et al. Stem cell-based tissue-engineered laryngeal replacement. Stem cells translational medicine. 2017 Feb 1;6(2):677-687. https://doi.org/10.5966/sctm.2016-0130
Ansari, Tahera ; Lange, Peggy ; Southgate, Aaron ; Greco, Karin ; Carvalho, Carla ; Partington, Leanne ; Bullock, Anthony ; Macneil, Sheila ; Lowdell, Mark W. ; Sibbons, Paul D. ; Birchall, Martin A. / Stem cell-based tissue-engineered laryngeal replacement. In: Stem cells translational medicine. 2017 ; Vol. 6, No. 2. pp. 677-687.
@article{9c6941a55cf849ce81b0ca1a6edefa20,
title = "Stem cell-based tissue-engineered laryngeal replacement",
abstract = "Patients with laryngeal disorders may have severe morbidity relating to swallowing, vocalization, and respiratory function, for which conventional therapies are suboptimal. A tissue-engineered approach would aim to restore the vocal folds and maintain respiratory function while limiting the extent of scarring in the regenerated tissue. Under Good Laboratory Practice conditions, we decellularized porcine larynges, using detergents and enzymes under negative pressure to produce an acellular scaffold comprising cartilage, muscle, and mucosa. To assess safety and functionality before clinical trials, a decellularized hemilarynx seeded with human bone marrow-derived mesenchymal stem cells and a tissue-engineered oral mucosal sheet was implanted orthotopically into six pigs. The seeded grafts were left in situ for 6 months and assessed using computed tomography imaging, bronchoscopy, and mucosal brushings, together with vocal recording and histological analysis on explantation. The graft caused no adverse respiratory function, nor did it impact swallowing or vocalization. Rudimentary vocal folds covered by contiguous epithelium were easily identifiable. In conclusion, the proposed tissue-engineered approach represents a viable alternative treatment for laryngeal defects.",
keywords = "Animal model, Human stem cell, Larynx, Tissue engineering, Tissue scaffold",
author = "Tahera Ansari and Peggy Lange and Aaron Southgate and Karin Greco and Carla Carvalho and Leanne Partington and Anthony Bullock and Sheila Macneil and Lowdell, {Mark W.} and Sibbons, {Paul D.} and Birchall, {Martin A.}",
year = "2017",
month = "2",
day = "1",
doi = "10.5966/sctm.2016-0130",
language = "English (US)",
volume = "6",
pages = "677--687",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - Stem cell-based tissue-engineered laryngeal replacement

AU - Ansari, Tahera

AU - Lange, Peggy

AU - Southgate, Aaron

AU - Greco, Karin

AU - Carvalho, Carla

AU - Partington, Leanne

AU - Bullock, Anthony

AU - Macneil, Sheila

AU - Lowdell, Mark W.

AU - Sibbons, Paul D.

AU - Birchall, Martin A.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Patients with laryngeal disorders may have severe morbidity relating to swallowing, vocalization, and respiratory function, for which conventional therapies are suboptimal. A tissue-engineered approach would aim to restore the vocal folds and maintain respiratory function while limiting the extent of scarring in the regenerated tissue. Under Good Laboratory Practice conditions, we decellularized porcine larynges, using detergents and enzymes under negative pressure to produce an acellular scaffold comprising cartilage, muscle, and mucosa. To assess safety and functionality before clinical trials, a decellularized hemilarynx seeded with human bone marrow-derived mesenchymal stem cells and a tissue-engineered oral mucosal sheet was implanted orthotopically into six pigs. The seeded grafts were left in situ for 6 months and assessed using computed tomography imaging, bronchoscopy, and mucosal brushings, together with vocal recording and histological analysis on explantation. The graft caused no adverse respiratory function, nor did it impact swallowing or vocalization. Rudimentary vocal folds covered by contiguous epithelium were easily identifiable. In conclusion, the proposed tissue-engineered approach represents a viable alternative treatment for laryngeal defects.

AB - Patients with laryngeal disorders may have severe morbidity relating to swallowing, vocalization, and respiratory function, for which conventional therapies are suboptimal. A tissue-engineered approach would aim to restore the vocal folds and maintain respiratory function while limiting the extent of scarring in the regenerated tissue. Under Good Laboratory Practice conditions, we decellularized porcine larynges, using detergents and enzymes under negative pressure to produce an acellular scaffold comprising cartilage, muscle, and mucosa. To assess safety and functionality before clinical trials, a decellularized hemilarynx seeded with human bone marrow-derived mesenchymal stem cells and a tissue-engineered oral mucosal sheet was implanted orthotopically into six pigs. The seeded grafts were left in situ for 6 months and assessed using computed tomography imaging, bronchoscopy, and mucosal brushings, together with vocal recording and histological analysis on explantation. The graft caused no adverse respiratory function, nor did it impact swallowing or vocalization. Rudimentary vocal folds covered by contiguous epithelium were easily identifiable. In conclusion, the proposed tissue-engineered approach represents a viable alternative treatment for laryngeal defects.

KW - Animal model

KW - Human stem cell

KW - Larynx

KW - Tissue engineering

KW - Tissue scaffold

UR - http://www.scopus.com/inward/record.url?scp=85017642092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017642092&partnerID=8YFLogxK

U2 - 10.5966/sctm.2016-0130

DO - 10.5966/sctm.2016-0130

M3 - Article

AN - SCOPUS:85017642092

VL - 6

SP - 677

EP - 687

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 2

ER -